Chaining Injunctions: The Strategic Architecture of De Facto Exclusivity Extension
In the high-stakes world of pharmaceutical innovation, the race to extend market exclusivity can sometimes resemble a game of chess—strategic, calculated, and often controversial. Recent insights from DrugPatentWatch shed light on a sophisticated tacti…
Chaining Injunctions: The Strategic Architecture of De Facto Exclusivity Extension Read Post »
